Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze

Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Breeze.

Inclusion Criteria:

• Integral skin test in the region;

Exclusion Criteria:

• Lactation or gestational risk or gestation;
• Use of Anti-inflammatory or immunosuppression drugs 1 month before the study;
• Topical medication use at the region to be treated;
• Cutaneous disease or active gynecological disease which may interfere in study results;
• Personal history of allergic disease at the area to be treated;
• Allergic or atopic history;

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.